BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01292135-completion@plaintrial.com
DTSTAMP:20261027T194114Z
DTSTART;VALUE=DATE:201305
SUMMARY:Safety and Tolerability Study of PCI-32765 Combined With Fludarabin
 e/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chro
 nic Lymphocytic Leukemia (CLL) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01292135
URL:https://plaintrial.com/trial/NCT01292135
END:VEVENT
END:VCALENDAR